From: Serum anti-SPP1 autoantibody as a potential novel biomarker in detection of esophageal squamous cell carcinoma
Serum
N (%)
P
Discovery group
ESCC(n = 62)
28(45.16%)
 < 0.001
NC(n = 62)
10(16.13%)
Validation group
ESCC(n = 100)
41(41.00%)
NC(n = 100)
13(13.00%)